|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.74 CNY | +0.15% |
|
-3.80% | -14.77% |
Yixintang Pharmaceutical Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 8,675.54 million compared to CNY 7,965.02 million a year ago. Net income was CNY 504.58 million compared to CNY 418.24 million a year ago.
Basic earnings per share from continuing operations was CNY 0.8489 compared to CNY 0.706 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.77% | 1.62B | |
| -32.21% | 15.27B | |
| -31.97% | 10.84B | |
| -30.42% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
YIXINTANG PHARMACEUTICAL GROUP CO., LTD. 
